documents: FDA-2021-D-1140-0001

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2021-D-1140-0001 FDA FDA-2021-D-1140 Investigational New Drug Application Submissions for Individualized Antisense Oligonucleotide Drug Products for Severely Debilitating or Life-Threatening Diseases: Clinical Recommendations; Draft Guidance for Sponsor-Investigators; Availability Notice Notice of Availability 2021-12-08T05:00:00Z 2021 12 2021-12-08T05:00:00Z   2021-12-08T14:19:49Z 2021-26453 0 0 0900006484eaeede

Links from other tables